Kirby Institute
Clinical trials sponsored by Kirby Institute, explained in plain language.
-
Massive angola trial pits moxidectin against ivermectin to end river blindness
Disease control Recruiting nowThis study compares two FDA-approved drugs, moxidectin and ivermectin, to see which is better at reducing river blindness and other parasitic infections when given yearly to entire communities in Angola. Over 52,000 people will take part, and researchers will track infection rate…
Phase: PHASE4 • Sponsor: Kirby Institute • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Finger-Prick test aims to find hidden hepatitis c cases
Knowledge-focused Recruiting nowThis study is testing whether a quick finger-stick test can help find more people with hepatitis C and connect them to treatment. Researchers will offer the test to 60,000 people at high risk, such as those visiting drug treatment clinics or prisons. Participants take a single te…
Sponsor: Kirby Institute • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC
-
Booster before or after? study seeks best COVID protection for Immune-Weak patients
Knowledge-focused Recruiting nowThis study looks at 320 adults who need strong immune-suppressing drugs and have already had at least two COVID-19 vaccines. Researchers want to know if giving a booster right before starting treatment or waiting six months provides better protection. The goal is to find the safe…
Phase: PHASE3 • Sponsor: Kirby Institute • Aim: Knowledge-focused
Last updated May 04, 2026 16:23 UTC